{
    "symbol": "ENZ",
    "quarter": 3,
    "year": 2022,
    "date": "2022-06-10 10:17:02",
    "content": " Enzo Life Sciences revenue was $7.6 million in Q3 consistent year-over-year and an increase of 9% on a year-to-date basis, demonstrating stability in the ELS customer base. This new website is specifically designed to optimize our transactional capabilities and rival other e-commerce sites in Life Sciences area, while strengthening Enzo's brand awareness, facilitating customer integration and an easy to use portal to review product details and providing a frictionless, reordering platform, we will continue to invest in technology initiatives where there is ability to save costs, enhance our products and service or accelerate revenues. On divisional basis, Enzo Clinical Lab Service revenue for the third quarter was $18.6 million, a decrease of 26% from $25 million in the third quarter of fiscal year 2021. On the Life Sciences side of the business, revenue for the third quarter was $7.6 million, a slight decrease year-over-year and revenue increased 9% on a year-to-date basis, demonstrating stability in the ELS customer base."
}